Verona Pharma plc (VRNA:NASDAQ) jumped higher at $6.58, representing a gain of 44.9%.
About Verona Pharma plc (VRNA:NASDAQ)
Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators.
Top 10 Gainers:
- China Rapid Finance Limited (XRF:NYSE), 113.11%
- Mereo BioPharma Group plc (MREO:NASDAQ), 97.25%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 54.1%
- Tetraphase Pharmaceuticals, Inc. (TTPH:NASDAQ), 50%
- Phathom Pharmaceuticals, Inc. (PHAT:NASDAQ), 47.21%
- Verona Pharma plc (VRNA:NASDAQ), 44.93%
- Liquidia Technologies, Inc. (LQDA:NASDAQ), 43.47%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 43.23%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 37.49%
- KemPharm, Inc. (KMPH:NASDAQ), 34.79%